{
  "thread": {
    "uuid": "2ef74a1d5e6024d734e33763fe8a3c17a3b44e71",
    "url": "https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3313028.shtml",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.cn/",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "æ°æµªè´¢ç»_éèä¿¡æ¯æå¡å",
    "title": "益方生物股价跌5.1%，永赢基金旗下1只基金位居十大流通股东，持有792.19万股浮亏损失1283.35万元|收益_新浪财经_新浪网",
    "title_full": "益方生物股价跌5.1%，永赢基金旗下1只基金位居十大流通股东，持有792.19万股浮亏损失1283.35万元|收益_新浪财经_新浪网",
    "published": "2026-01-15T07:58:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 548,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "2ef74a1d5e6024d734e33763fe8a3c17a3b44e71",
  "url": "https://finance.sina.com.cn/money/fund/aiassistant/zcgyd/2026-01-15/doc-inhhkmpv3313028.shtml",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2026-01-15T07:58:00.000+02:00",
  "title": "益方生物股价跌5.1%，永赢基金旗下1只基金位居十大流通股东，持有792.19万股浮亏损失1283.35万元|收益_新浪财经_新浪网",
  "text": "1月15日， 益方生物 跌5.1%，截至发稿，报30.12元/股，成交3.36亿元，换手率2.60%，总市值174.20亿元。\n资料显示，益方生物科技(上海)股份有限公司位于中国(上海)自由贸易试验区李冰路67弄4号210室,香港湾仔皇后大道东183号合和中心46楼，成立日期2013年1月11日，上市日期2022年7月25日，公司主营业务涉及创新药物的研发、生产和销售。主营业务收入构成为：技术授权和技术合作收入100.00%。\n从益方生物十大流通股东角度\n数据显示，永赢基金旗下1只基金位居益方生物十大流通股东。永赢医药创新智选混合发起A（015915）三季度新进十大流通股东，持有股数792.19万股，占流通股的比例为1.9%。根据测算，今日浮亏损失约1283.35万元。\n永赢医药创新智选混合发起A（015915）成立日期2022年11月22日，最新规模11.87亿。今年以来收益12.67%，同类排名485/8840；近一年收益98.19%，同类排名158/8094；成立以来收益78.53%。\n永赢医药创新智选混合发起A（015915）基金经理为单林。\n截至发稿，单林累计任职时间1年209天，现任基金资产总规模81.81亿元，任职期间最佳基金回报105.32%， 任职期间最差基金回报19.9%。\n从基金十大重仓股角度\n数据显示，永赢基金旗下1只基金重仓益方生物。永赢医药健康A（008618）三季度增持30.47万股，持有股数51.35万股，占基金净值比例为4.53%，位居第五大重仓股。根据测算，今日浮亏损失约83.19万元。\n永赢医药健康A（008618）成立日期2020年5月20日，最新规模3902.46万。今年以来收益16.46%，同类排名208/5525；近一年收益28.22%，同类排名2776/4208；成立以来收益13.55%。\n永赢医药健康A（008618）基金经理为单林。\n截至发稿，单林累计任职时间1年209天，现任基金资产总规模81.81亿元，任职期间最佳基金回报105.32%， 任职期间最差基金回报19.9%。\n风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建议。\nMACD金叉信号形成，这些股涨势不错！",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->financial service",
    "Economy, Business and Finance->business reporting and performance"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [
    "https://finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://www.finance.sina.cn/app/sfa_macd.shtml?source=pccj",
    "https://finance.sina.cn/app/sfa_macd.shtml"
  ],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:02:05.660+02:00",
  "updated": "2026-01-16T08:06:45.000+02:00"
}